Fanni Gergely elected to EMBO Membership
Dr Fanni Gergely, Senior Group Leader at the Institute, has been elected as a member of the European Molecular Biology Organisation (EMBO) in recognition of her high quality life science research.
Fanni is one of 56 new members who are joining more than 1800 of the best researchers in Europe and around the world.
Election to EMBO Membership is recognition of research excellence and the outstanding achievements made by a life scientist. EMBO Members actively participate in the execution of the organisation’s initiatives by serving on Council, committees and editorial boards, and by evaluating applications for EMBO funding. As a result, EMBO Members collectively influence the future directions of life science research and strengthen research communities across Europe.
It is an honour to be elected a member of EMBO. This award also recognises the research efforts of my talented team and fantastic collaborators
Dr Fanni Gergely, Cancer Research UK Cambridge Institute
Fanni’s research seeks to understand how centrosomes contribute to normal and pathological processes such as embryonic growth, neurodevelopment and tumourigenesis. By using a combination of genetic, molecular and proteomic tools, her team interrogates the roles of centrosome components in cell proliferation and signalling. Most recently, the group’s work is focused on identifying tissue-specific functions for these ubiquitous organelles.
“It is an honour to be elected a member of EMBO by my peers. This award also recognises the research efforts of my talented team and fantastic collaborators, all made possible by the invaluable support of Cancer Research UK and the Cambridge Institute” says Fanni. “I look forward to contributing to EMBO’s valuable work strengthening the research community in Europe and beyond.”
EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines
Maria Leptin, EMBO Director
“EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution,” says EMBO Director Maria Leptin.
The new EMBO Members and Associate Members will be formally welcomed at the annual Members’ Meeting in Heidelberg between 29 and 31 October 2019.
Read more
Cambridge scientists recognised by major European research organisation
Related News
See all news-
Dr Guiping Wang appointed as a Junior Group Leader
18th May 2026
Dr Guiping Wang joins the Cancer Research UK Cambridge Institute as a Junior Group Leader, starting in September 2026.
Find out more -
Shankar Balasubramanian receives the Princess of Asturias Award for Scientific and Technical Research
14th May 2026
The 2026 award recognises Prof Balasubramanian and his co-recipients David Klenerman and Pascal Meyer for their pioneering work in genome sequencing technologies.
Find out more -
Prof Sir Steve Jackson receives the 2026 Galen Medal in Therapeutics
14th May 2026
This award comes in recognition of his transformational work on the mechanisms of DNA repair, cell survival and the DNA-damage response (DDR), as well as for the development of the cancer-targeting drug Olaparib.
Find out more